PUBLISHER: TechNavio | PRODUCT CODE: 2030967
PUBLISHER: TechNavio | PRODUCT CODE: 2030967
Global Viral Vector Manufacturing Market 2026-2030
The global viral vector manufacturing market is forecasted to grow by USD 5475.7 mn during 2025-2030, accelerating at a CAGR of 21.2% during the forecast period. The report on the global viral vector manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by robust pipeline and favorable regulatory environment, significant influx of capital and strategic investments, continuous innovation in manufacturing technologies and process optimization.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 17.5% |
| CAGR | 21.2% |
| Incremental Value | $5475.7 mn |
Technavio's global viral vector manufacturing market is segmented as below:
By Manufacturing Type
- In-house manufacturing
- Contract manufacturing
By Application
- Genetic disorders
- Infectious disease
- Cancer
- Neurological disorders
- Others
By Type
- Adeno-associated viral (AAV) vectors
- Lentiviral vectors
- Adenoviral vectors
- Others
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the strategic shift towards vertical integration and in-house manufacturing as one of the prime reasons driving the global viral vector manufacturing market growth during the next few years. Also, rise of standardized and templated production platforms and intensified focus on advanced analytical characterization and quality control will lead to sizable demand in the market.
The report on the global viral vector manufacturing market covers the following areas:
- Global viral vector manufacturing market sizing
- Global viral vector manufacturing market forecast
- Global viral vector manufacturing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global viral vector manufacturing market vendors that include ABL Inc., AGC Biologics, Aldevron LLC, Andelyn Biosciences, Batavia Biosciences BV, Charles River Laboratories International Inc., Forge Biologics Inc., FUJIFILM Holdings Corp., Genezen, Lonza Group Ltd., Novartis AG, OBiO Technology Corp. Ltd., Oxford Biomedica plc, Recipharm AB, REGENXBIO Inc, Sigma Aldrich Chemicals Ltd., Sirion Biotech GmbH, SK Pharmteco, Takara Bio Inc., Thermo Fisher Scientific Inc.. Also, the global viral vector manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Manufacturing Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Viral Vector Manufacturing Market 2020 - 2024
- Historic Market Size - Data Table on Global Viral Vector Manufacturing Market 2020 - 2024 ($ million)
- 5.2 Manufacturing Type segment analysis 2020 - 2024
- Historic Market Size - Manufacturing Type Segment 2020 - 2024 ($ million)
- 5.3 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.4 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global viral vector manufacturing market
- 6.2 Impact of geopolitical conflicts on global viral vector manufacturing market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Manufacturing Type
- 8.1 Market segments
- 8.2 Comparison by Manufacturing Type
- 8.3 In-house manufacturing - Market size and forecast 2025-2030
- 8.4 Contract manufacturing - Market size and forecast 2025-2030
- 8.5 Market opportunity by Manufacturing Type
- Market opportunity by Manufacturing Type ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Genetic disorders - Market size and forecast 2025-2030
- 9.4 Infectious disease - Market size and forecast 2025-2030
- 9.5 Cancer - Market size and forecast 2025-2030
- 9.6 Neurological disorders - Market size and forecast 2025-2030
- 9.7 Others - Market size and forecast 2025-2030
- 9.8 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Market Segmentation by Type
- 10.1 Market segments
- 10.2 Comparison by Type
- 10.3 Adeno-associated viral (AAV) vectors - Market size and forecast 2025-2030
- 10.4 Lentiviral vectors - Market size and forecast 2025-2030
- 10.5 Adenoviral vectors - Market size and forecast 2025-2030
- 10.6 Others - Market size and forecast 2025-2030
- 10.7 Market opportunity by Type
- Market opportunity by Type ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Thailand - Market size and forecast 2025-2030
- 12.5.6 Indonesia - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Argentina - Market size and forecast 2025-2030
- 12.6.7 Colombia - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Robust pipeline and favorable regulatory environment
- Significant influx of capital and strategic investments
- Continuous innovation in manufacturing technologies and process optimization
- 13.2 Market challenges
- Securing consistent and high-quality raw materials and consistent supply chain
- Analytical bottlenecks and characterization hurdles
- Critical shortage of highly specialized workforce
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Strategic shift towards vertical integration and in-house manufacturing
- Rise of standardized and templated production platforms
- Intensified focus on advanced analytical characterization and quality control
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 ABL Inc.
- ABL Inc. - Overview
- ABL Inc. - Product / Service
- ABL Inc. - Key offerings
- SWOT
- 15.5 AGC Biologics
- AGC Biologics - Overview
- AGC Biologics - Product / Service
- AGC Biologics - Key offerings
- SWOT
- 15.6 Aldevron LLC
- Aldevron LLC - Overview
- Aldevron LLC - Product / Service
- Aldevron LLC - Key offerings
- SWOT
- 15.7 Andelyn Biosciences
- Andelyn Biosciences - Overview
- Andelyn Biosciences - Product / Service
- Andelyn Biosciences - Key offerings
- SWOT
- 15.8 Charles River Laboratories International Inc.
- Charles River Laboratories International Inc. - Overview
- Charles River Laboratories International Inc. - Business segments
- Charles River Laboratories International Inc. - Key offerings
- Charles River Laboratories International Inc. - Segment focus
- SWOT
- 15.9 Forge Biologics Inc.
- Forge Biologics Inc. - Overview
- Forge Biologics Inc. - Product / Service
- Forge Biologics Inc. - Key offerings
- SWOT
- 15.10 FUJIFILM Holdings Corp.
- FUJIFILM Holdings Corp. - Overview
- FUJIFILM Holdings Corp. - Business segments
- FUJIFILM Holdings Corp. - Key news
- FUJIFILM Holdings Corp. - Key offerings
- FUJIFILM Holdings Corp. - Segment focus
- SWOT
- 15.11 Lonza Group Ltd.
- Lonza Group Ltd. - Overview
- Lonza Group Ltd. - Business segments
- Lonza Group Ltd. - Key offerings
- Lonza Group Ltd. - Segment focus
- SWOT
- 15.12 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 15.13 Oxford Biomedica plc
- Oxford Biomedica plc - Overview
- Oxford Biomedica plc - Product / Service
- Oxford Biomedica plc - Key offerings
- SWOT
- 15.14 REGENXBIO Inc
- REGENXBIO Inc - Overview
- REGENXBIO Inc - Product / Service
- REGENXBIO Inc - Key offerings
- SWOT
- 15.15 Sigma Aldrich Chemicals Ltd.
- Sigma Aldrich Chemicals Ltd. - Overview
- Sigma Aldrich Chemicals Ltd. - Product / Service
- Sigma Aldrich Chemicals Ltd. - Key offerings
- SWOT
- 15.16 SK Pharmteco
- SK Pharmteco - Overview
- SK Pharmteco - Product / Service
- SK Pharmteco - Key offerings
- SWOT
- 15.17 Takara Bio Inc.
- Takara Bio Inc. - Overview
- Takara Bio Inc. - Product / Service
- Takara Bio Inc. - Key offerings
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
